Navigation Links
Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting
Date:10/16/2009

impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and health care cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and succ
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
2. Plastic Surgery 2009 News Briefs - Selected Research to be Presented on Tuesday, October 27
3. Plastic Surgery 2009 News Briefs - Selected Research to be Presented on Monday, October 26
4. Plastic Surgery 2009 News Briefs - Select Research to be Presented on Sunday, October 25
5. Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24
6. Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009
7. PolyOne Presented with Frost & Sullivan Medical Product Award
8. CRF announces featured clinical trials to be presented at TCT 2009 in San Francisco
9. Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting
10. Centers of Excellence Awards Presented to Over 100 Nursing Facilities as Nursing Facilities Reach the Tipping Point in Treating Pressure Ulcers
11. CRF announces late breaking trials to be presented at TCT 2009 in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 30, 2014 Patients suffering from vitiligo ... in a new review published by Daily Gossip. , ... with, so there is no wonder that numerous sufferers ... Natural Vitiligo Treatment is one of the most appreciated ... Treatment promises to stop the spread of this disorder ...
(Date:8/30/2014)... 2014 The Plastic Surgery Group (PSG) ... and even in the U.S. to provide clients with ... of patients’ waists with deep-tissue heating. , Unlike Cryotherapy ... Vanquish is more inclusive to target large sections of ... under panels about one inch away from their body ...
(Date:8/30/2014)... The establishment and creation of ... one of the main strategies of the Church ... impact around the world. , Architecturally stellar buildings ... executives and trainers deliver L. Ron Hubbard's spiritual ... statistics demonstrate that significant reduction in crime, major ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Seniors Guide, the ... recently that focus on Alzheimer’s Disease, Dementia, and Memory ... to the public of being diagnosed with the Alzheimer’s, inspired ... movie, “I’ll Be Me”. The movie, out on October ... focusing on his diagnosis of the disease – which inspires ...
(Date:8/30/2014)... HealthDay Reporter FRIDAY, Aug. 29, 2014 (HealthDay ... broken bones or other orthopedic trauma shops around for additional ... patients and patients who had used narcotic painkillers previously were ... lead author Dr. Brent Morris, a shoulder and neck surgeon ... doctors aren,t talking to one another about the painkiller needs ...
Breaking Medicine News(10 mins):Health News:Natural Vitiligo Treatment Review Exposes Fast Method for Skin Repigmentation 2Health News:NJ Top Docs Presents, The Plastic Surgery Group 2Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2Health News:Alzheimer’s Disease and Dementia Focus on Retirement Website SeniorsGuideOnline.com 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 3
... comes news that specialist nurses may face cuts. This was ... to them some NHS trusts have identified them as a ... diabetes, multiple sclerosis, epilepsy, or a range of other long-term ... BBC survey that the overall health service deficit in England ...
... Bihar was left for herself to cremate the body of her ... a helping hand. The widow dragged his body to the backyard ... Dhanua Devi (named changed), a 36-year-old resident of Khaira village in ... to console her. ,A mother of three, she told ...
... Prime Minister Manmohan Singh has announced the set-up of ... the imbalances in the provision of health care services ... initiative that will redress the inequalities in financial management ... specializations in health care services. ,The Public Health ...
... Mothers , who carry a high risk of the ... consume large doses of Vitamin C and E. // ... not beneficial to pregnant women and can trigger pre-eclampsia. ... of Blood pressure in pregnant women which is a common ...
... doctors say that after the new reforms very few patients were ... a radical overhaul of dental charges to take effect next week. ... the NHS. A survey showed that out of 45 local dentists ... result. ,The survey was carried out for ITV1's Tonight ...
... question papers of the MD/MS and PG Diploma courses entrance ... (AIIMS), // has been identified as a post-graduate student, ... ,Satish Kumar (26),an MD (Paediatric) student, along with Ravi Kannan ... been taken into custody by the Central Bureau of ...
Cached Medicine News:
(Date:8/29/2014)... WILSONVILLE, Ore. , Aug. 29, 2014 /PRNewswire-iReach/ ... its Accessory (Axilla) Strap for the SAM Junctional ... SAM Medical Products announced ... a voluntary recall to address a potential issue ... strap used for the Axilla application of the ...
(Date:8/29/2014)... PARK, Calif. , Aug. 29, 2014 ... Medical as CEO and member of the Board of ... decades of medical device development and commercialization experience, including ... field. Mr. Engelson previously served as a Partner of ... as President and CEO of two Foundry start-ups. Mr. ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... Peptide Cancer Therapeutics Market & Pipeline Insight 2014" ... methods developed to prevent and eradicate the prevalence of ... methods are confined to low specificity, safety and large ... look for a better solution. It has been discovered ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2
... Inc.,(Nasdaq: VRUS ), a clinical stage pharmaceutical ... to treat viral,infections, reported unaudited financial results for ... 2007. Pharmasset reported a net loss,attributable to common ... the first fiscal quarter of 2008, as compared ...
... and MONTREAL, Feb. 14 Pharmion,Corporation (Nasdaq: ... announced,that the U.S. Food and Drug Administration (FDA) ... as an Orphan,Drug for the treatment of acute ... designation require that the product be intended for,treatment ...
Cached Medicine Technology:Pharmasset Reports First Fiscal Quarter 2008 Financial Results 2Pharmasset Reports First Fiscal Quarter 2008 Financial Results 3Pharmasset Reports First Fiscal Quarter 2008 Financial Results 4Pharmasset Reports First Fiscal Quarter 2008 Financial Results 5Pharmasset Reports First Fiscal Quarter 2008 Financial Results 6Pharmasset Reports First Fiscal Quarter 2008 Financial Results 7Pharmasset Reports First Fiscal Quarter 2008 Financial Results 8Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 3Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 4
Ergotec sterilization tray...
For sterilizing, carrying and storage of a Storz diamond knife and barrel gauge....
Size: 3 x 6 inches. Depth: 1 inch. Sterilizable plastic tray with silicone matting for supporting and protecting instruments....
Lance shaped gently curved tip. Flat serrated handle with polished finish....
Medicine Products: